Emerging immunotherapies in older adults with acute myeloid leukemia

od Vasu, Sumithira, Blum, William
Izdano 2013

Targeted immunotherapy for acute myeloid leukemia

od Vasu, Sumithira, Caligiuri, Michael A.
Izdano 2011

The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60 years

od Wall, Sarah A., Devine, Steven, Vasu, Sumithira
Izdano u Blood Rev (2017)

Discharge disposition following hematopoietic cell transplantation: Predicting need for rehabilitation and association with survival

od Wall, Sarah A., Zhao, Qiuhong, Vasu, Sumithira, Rosko, Ashley
Izdano u Transplant Cell Ther (2020)

A Novel Method to Expand Large Numbers of CD56(+)Natural Killer Cells from a Minute Fraction of Selectively Accessed Cryopreserved Cord Blood for Immunotherapy Post-transplantation

od Vasu, Sumithira, Berg, Maria, Davidson-Moncada, Jan, Tian, Xin, Cullis, Herb, Childs, Richard W.
Izdano u Cytotherapy (2015)

Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia

od Patel, Sandipkumar H., Vasu, Sumithira, Guo, Ling, Lemaster, Olivia, Byrd, John C., Walker, Alison
Izdano u J Natl Compr Canc Netw (2020)

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

od Kent, Andrew, Vasu, Sumithira, Schatz, Derek, Monson, Natalie, Devine, Steven, Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Izdano u Blood Adv (2020)

Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia

od Mani, Rajeswaran, Rajgolikar, Girish, Nunes, Jessica, Zapolnik, Kevan, Wasmuth, Ronni, Mo, Xiaokui, Byrd, John C., Lee, Dean A., Muthusamy, Natarajan, Vasu, Sumithira
Izdano u Cytotherapy (2020)

FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome

od He, Shun, Chu, Jianhong, Vasu, Sumithira, Deng, Youcai, Yuan, Shunzong, Zhang, Jianying, Fan, Zhijin, Hofmeister, Craig C., He, Xiaoming, Marsh, Henry C., Devine, Steven M., Yu, Jianhua
Izdano 2013

Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types

od Kulkarni, Amit A, Ebadi, Maryam, Zhang, Shijia, Meybodi, Mohamad A, Ali, Alaa M, DeFor, Todd, Shanley, Ryan, Weisdorf, Daniel, Ryan, Charles, Vasu, Sumithira, Rashidi, Armin, Patel, Manish Ramesh
Izdano u ESMO Open (2020)

Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

od Pantin, Jeremy, Tian, Xin, Geller, Nancy, Ramos, Catalina, Cook, Lisa, Cho, Elena, Scheinberg, Phillip, Vasu, Sumithira, Khuu, Hahn, Stroncek, David, Barrett, John, Young, Neal S., Donohue, Theresa, Childs, Richard W.
Izdano 2014

Midostaurin, Bortezomib and MEC in Relapsed/Refractory Acute Myeloid Leukemia

od Walker, Alison R., Wang, Hongyan, Walsh, Katherine, Bhatnagar, Bhavana, Vasu, Sumithira, Garzon, Ramiro, Canning, Renee, Geyer, Susan, Wu, Yue-Zhong, Devine, Steven M., Klisovic, Rebecca, Blum, William, Marcucci, Guido
Izdano u Leuk Lymphoma (2016)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

od Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Izdano 2014

Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem...

od Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Izdano u Leuk Lymphoma (2014)

Activation of the intracellular pattern-recognition receptor NOD2 promotes acute myeloid leukemia cell apoptosis and provides a survival advantage in an animal model of AML

od Buteyn, Nathaniel J., Santhanam, Ramasamy, Merchand-Reyes, Giovanna, Murugesan, Rakesh A., Dettorre, Gino M., Byrd, John C., Sarkar, Anasuya, Vasu, Sumithira, Mundy-Bosse, Bethany L., Butchar, Jonathan P., Tridandapani, Susheela
Izdano u J Immunol (2020)

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

od Gopalakrishnan, Bhavani, Cheney, Carolyn, Mani, Rajeswaran, Mo, Xiaokui, Bucci, Donna, Walker, Alison, Klisovic, Rebecca, Bhatnagar, Bhavana, Walsh, Katherine, Rueter, Bjoern, Waizenegger, Irene C., Heider, Karl-Heinz, Blum, William, Vasu, Sumithira, Muthusamy, Natarajan
Izdano u Oncotarget (2018)

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

od Ranganathan, Parvathi, Yu, Xueyan, Santhanam, Ramasamy, Hofstetter, Jessica, Walker, Alison, Walsh, Katherine, Bhatnagar, Bhavana, Klisovic, Rebecca, Vasu, Sumithira, Phelps, Mitch A., Devine, Steven, Shacham, Sharon, Kauffman, Michael, Marcucci, Guido, Blum, William, Garzon, Ramiro
Izdano u Blood (2015)

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acut...

od Vij, Ravi, Le-Rademacher, Jennifer, Laumann, Kristina, Hars, Vera, Owzar, Kouros, Shore, Tsiporah, Vasu, Sumithira, Cashen, Amanda, Isola, Luis, Shea, Thomas, DeMagalhaes-Silverman, Margarida, Hurd, David, Meehan, Kenneth, Beardell, Frank, Devine, Steven
Izdano u Biol Blood Marrow Transplant (2019)

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

od Jeon, Jae Yoon, Zhao, Qiuhong, Buelow, Daelynn R., Phelps, Mitch, Walker, Alison R., Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory, Blachly, James, Blum, William, Klisovic, Rebecca B., Byrd, John C., Garzon, Ramiro, Baker, Sharyn D., Bhatnagar, Bhavana
Izdano u Invest New Drugs (2019)

Selinexor in Combination with Decitabine in Patients with Acute Myeloid Leukemia: Results from a Phase 1 study

od Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory K., Larkin, Karilyn, Blachly, James S., Blum, William, Klisovic, Rebecca B., Ruppert, Amy S., Orwick, Shelley, Oakes, Christopher, Ranganathan, Parvathi, Byrd, John C., Walker, Alison R., Garzon, Ramiro
Izdano u Leuk Lymphoma (2019)